These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 23083550)

  • 1. Molecular and functional ultrasound imaging of breast tumors.
    Bzyl J; Lederle W; Palmowski M; Kiessling F
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S11-2. PubMed ID: 23083550
    [No Abstract]   [Full Text] [Related]  

  • 2. Establishment of functional and molecular ultrasound for breast cancer xenograft imaging.
    Bzyl J
    Rofo; 2014 Apr; 186(4):377-9. PubMed ID: 24683170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis.
    Pochon S; Tardy I; Bussat P; Bettinger T; Brochot J; von Wronski M; Passantino L; Schneider M
    Invest Radiol; 2010 Feb; 45(2):89-95. PubMed ID: 20027118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of repetitive contrast agent injections on functional and molecular ultrasound measurements.
    Rix A; Palmowski M; Gremse F; Palmowski K; Lederle W; Kiessling F; Bzyl J
    Ultrasound Med Biol; 2014 Oct; 40(10):2468-75. PubMed ID: 25023096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral enhancement of breast cancers on contrast-enhanced ultrasound: correlation with microvessel density and vascular endothelial growth factor expression.
    Liu H; Jiang Y; Dai Q; Zhu Q; Wang L; Lu J
    Ultrasound Med Biol; 2014 Feb; 40(2):293-9. PubMed ID: 24315392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VEGFR2-targeted molecular imaging in the mouse embryo: an alternative to the tumor model.
    Denbeigh JM; Nixon BA; Hudson JM; Puri MC; Foster FS
    Ultrasound Med Biol; 2014 Feb; 40(2):389-99. PubMed ID: 24342913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging of thyroid tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice.
    Mancini M; Greco A; Salvatore G; Liuzzi R; Di Maro G; Vergara E; Chiappetta G; Pasquinelli R; Brunetti A; Salvatore M
    BMC Med Imaging; 2013 Sep; 13():31. PubMed ID: 24028408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasound Molecular Imaging of the Breast Cancer Neovasculature using Engineered Fibronectin Scaffold Ligands: A Novel Class of Targeted Contrast Ultrasound Agent.
    Abou-Elkacem L; Wilson KE; Johnson SM; Chowdhury SM; Bachawal S; Hackel BJ; Tian L; Willmann JK
    Theranostics; 2016; 6(11):1740-52. PubMed ID: 27570547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Lipopeptide-Based αvβ₃ Integrin-Targeted Ultrasound Contrast Agent for Molecular Imaging of Tumor Angiogenesis.
    Yan F; Xu X; Chen Y; Deng Z; Liu H; Xu J; Zhou J; Tan G; Wu J; Zheng H
    Ultrasound Med Biol; 2015 Oct; 41(10):2765-73. PubMed ID: 26166460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular ultrasound imaging using contrast agents targeting endoglin, vascular endothelial growth factor receptor 2 and integrin.
    Leguerney I; Scoazec JY; Gadot N; Robin N; Pénault-Llorca F; Victorin S; Lassau N
    Ultrasound Med Biol; 2015 Jan; 41(1):197-207. PubMed ID: 25308938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted contrast-enhanced ultrasound imaging of angiogenesis in an orthotopic mouse tumor model of renal carcinoma.
    Wei S; Fu N; Sun Y; Yang Z; Lei L; Huang P; Yang B
    Ultrasound Med Biol; 2014 Jun; 40(6):1250-9. PubMed ID: 24613557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Ultrasound Imaging.
    Baier J; Rix A; Kiessling F
    Recent Results Cancer Res; 2020; 216():509-531. PubMed ID: 32594397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative Nonlinear Contrast-Enhanced Ultrasound of the Breast.
    Sridharan A; Eisenbrey JR; Dave JK; Forsberg F
    AJR Am J Roentgenol; 2016 Aug; 207(2):274-81. PubMed ID: 27223688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between retention of a vascular endothelial growth factor receptor 2 (VEGFR2)-targeted ultrasonographic contrast agent and the level of VEGFR2 expression in an in vivo breast cancer model.
    Lee DJ; Lyshchik A; Huamani J; Hallahan DE; Fleischer AC
    J Ultrasound Med; 2008 Jun; 27(6):855-66. PubMed ID: 18499845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular ultrasound imaging: Clinical applications].
    Rix A; Palmowski M; Kiessling F
    Radiologe; 2015 Nov; 55(11):956-63. PubMed ID: 26438094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular ultrasound imaging using a targeted contrast agent for assessing early tumor response to antiangiogenic therapy.
    Sorace AG; Saini R; Mahoney M; Hoyt K
    J Ultrasound Med; 2012 Oct; 31(10):1543-50. PubMed ID: 23011617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Science to Practice: exploring new indications for molecular US imaging.
    Kiessling F
    Radiology; 2013 Jun; 267(3):661-2. PubMed ID: 23704288
    [No Abstract]   [Full Text] [Related]  

  • 18. Quantitative ultrasound molecular imaging by modeling the binding kinetics of targeted contrast agent.
    Turco S; Tardy I; Frinking P; Wijkstra H; Mischi M
    Phys Med Biol; 2017 Mar; 62(6):2449-2464. PubMed ID: 28240217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to optimize breast ultrasound.
    Athanasiou A; Tardivon A; Ollivier L; Thibault F; El Khoury C; Neuenschwander S
    Eur J Radiol; 2009 Jan; 69(1):6-13. PubMed ID: 18818037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New potential and applications of contrast-enhanced ultrasound of the breast: Own investigations and review of the literature.
    Balleyguier C; Opolon P; Mathieu MC; Athanasiou A; Garbay JR; Delaloge S; Dromain C
    Eur J Radiol; 2009 Jan; 69(1):14-23. PubMed ID: 18977102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.